Topical anti-inflammatory drug therapy

Details Topical anti-inflammatory drug therapy Topical anti-inflammatory drug therapy

1977-04-20

1980-01-22

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

424275, A61K 3138, A61K 3156

Patent

active

041851005

ABSTRACT:
A pharmaceutical composition for topical treatment of cutaneous disorders or disruptions characterized by skin inflammation or hyperproliferative epidermal activity comprises the combination of a topically active anti-inflammatory corticosteroid and a non-steroidal anti-inflammatory agent which is an inhibitor of prostaglandin synthetase selected from the group consisting of the hydratropic acid derivatives; acetylsalicylic acid; the pyrazolone derivatives; the fenamic acid derivatives; the aroyl-substituted pyrroles and the substituted arylacetohydroxamic acids in a pharmaceutically acceptable topical vehicle. Treatment of above cutaneous disorders may also be effected by concurrent therapy using separate applications of corticosteroid and non-steroid.

REFERENCES:
patent: 3243344 (1966-03-01), Senda
patent: 3374145 (1968-03-01), Enkoji et al.
patent: 3461208 (1969-08-01), Winter
patent: 3479396 (1969-11-01), Buu-Hoi et al.
patent: 3676464 (1972-07-01), Foden
patent: 3721680 (1973-03-01), Carson
patent: 3752826 (1973-08-01), Carson
patent: 3818048 (1974-06-01), Foden
patent: 4012508 (1977-03-01), Benton
Fries et al., Arthritis and Rheumatism, vol. 16, No. 5, (Sep., Oct.), 1973, pp. 629-634.
Mills et al., British Med. Journal, 13 Oct. 1973, vol. 4, pp. 82-84.
Bleckman et al., J.A.M.A., Jul. 28, 1975, vol. 233, No. 4.
Glenn et al., Agents & Actions, vol. 314, (1973), pp. 210-216.
Austria Codex (1975/76), pp. 353, 397, 398, 755, 27, 182, & 392.
"Die Pharmazie", vol. 28, (1973), pp. 569-570.
FDA, vol. 17, (1973), pp. 433, 468-470.
FDA, vol. 10, (1966), pp. 139, 158, 159, 186, 187, 183-185.
Fried et al., Scand. J. Rheumatology, Supp. 2: 7-11, (1973).
C. & E.N., Dec. 10, 1956, p. 6025.
Denko et al., Proc. Soc. Exp. Biol. Med., pp. 483-484, Jul. 1957.
Floman et al., Investigative Ophthalmology & Visual Science, vol. 16, No. 1, pp. 69-73, (Jan. 1977).
Weirich et al., Dermatologica, 152, 87-99.
Unlisted Drugs, vol. 25, No. 4, p. 60, Apr. 1973.
Bem et al., Arch. Derm. Forsch, 251: 35-41, (1974).
Snyder et al., Brit. J. Derm. 90: 91-93, (1974).
Snyder et al., J. Invest. Derm. 62: 47-50, (1974).
Goldyne et al., Prostaglandins, 4: 737-749, (1973).
Hsia et al., Prostaglandin Synthetase Inhibitors, pp. 353-361, (1974).
Skin & Allergy News, 8 (12): 2, (1977).
Lisciani et al., Japan J. Pharmacol., 25, pp. 101-107, (1975).

Affiliated with

Also associated with

Rating

Topical anti-inflammatory drug therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Topical anti-inflammatory drug therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical anti-inflammatory drug therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-334518